Similar Stories to Better Buy: Cvs Health Corporation Vs. Express Scripts on Bing News

newsfeedback@fool.com (Keith Speights), The Motley Fool
Sun, 04/22/2018 - 3:31am

The U.S. healthcare industry is in the middle of an upheaval. Lines between health insurers, pharmacies, and pharmacy benefits managers (PBMs) are becoming increasingly blurred. There are probably no better examples of this than CVS Health Corporation (NYSE: CVS) and Express Scripts (NASDAQ: ESRX).CVS Health ranks as the largest pharmacy chain and the second-largest PBM in the U.S.

PREV NEXT
Topics:  pbms   cvs health corporation nyse    nasdaq   esrx).cvs health   u.s in december   aet    pbm in march   cigna nyse   ci    u.s   u.s    pbm   cvs    cvs health   express   scripts   u.s     nyse   announced   insurer   pharmacy   
BING NEWS:
  • CVS Health: Show-Me Story Is Dead For The Near Term
    CVS Health reported terrible Q1 earnings and cut FY24 EPS guidance. Read why I view management's credibility in executing its show-me story as highly challenged.
    05/4/2024 - 9:35 pm | View Link
  • CVS Health: A Terrible Earnings Report, But An Undervalued Stock
    CVS Health's dismal earnings led to the largest one-day stock drop on record, but while its valuation is compelling, recovery may take time. See more here.
    05/3/2024 - 11:16 pm | View Link
  • The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
    The Law Offices of Frank R. Cruz announces an investigation of CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS) on behalf of investors concerning the Company's possible violations of ...
    05/2/2024 - 11:11 am | View Link
  • CVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript
    Q1 2024 Earnings Call Transcript May 1, 2024 CVS Health Corporation misses on earnings expectations. Reported EPS is $1.31 EPS, expectations were $1.7. CVS Health Corporation isn’t one of the 30 most ...
    05/2/2024 - 3:56 am | View Link
  • CVS Health Hold Rating Justified by Guidance Reduction and Uncertain Cost Trends
    Analyst Steve Baxter of Wells Fargo maintained a Hold rating on CVS Health (CVS – Research Report), retaining the price target of $76.00.
    05/1/2024 - 10:19 pm | View Link
  • More
PREV NEXT

 

PREV NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News